Vaccine sceptic Novak Djokovic holds major stakes in a firm developing Covid drug, says CEO

Updated : Jan 20, 2022 09:37
|
Editorji News Desk

Covid vaccine sceptic Novak Djokovic who bore the brunt of his denial after he was sent back from Australia holds major stakes in a firm developing Covid-19 drugs, confirmed the Danish Company's CEO. 

Also Read Premier League: Marcus Rashford ends goal drought as Man United beat Brentford 3-1

He is one of the founders of my company, which we founded in June 2020, the CEO of QuantBioRes Ivan Loncarevic said on Wednesday. As per the information available publicly, the 20-time Grand Slam Champion who missed his chance at the ongoing Australian Open due to the vaccination row holds 80% stakes in the company along with his wife Jelena. 

Loncarevic informed that his company is working for drugs against different viruses and are using Covid as a showcase. 

The 9+time Australian Open Champion had a dramatic start to the year after the Australian government denied his entry in Melbourne due to his vaccination status. The World no. 1 was sent back just before the start of the first Grand Slam of the year.  

AUS OPENNovak DjokovicGrand slam

Recommended For You

editorji | Sports

Kohli, Gaikwad hundreds in vain as South Africa chase 359 to level ODI series

editorji | Sports

Fit-again Gill, Pandya picked for T20I series against South Africa

editorji | Sports

India's jersey for 2026 T20 World Cup revealed

editorji | Sports

Harshit Rana reprimanded for aggressive behaviour against South Africa's Brewis

editorji | Sports

Virat Kohli moves up to No. 4 in ICC ODI rankings